References
- BalmesJRFineJMChristianD1988Acidity potentiates bronchoconstriction induced by hypoosmolar aerosolsAm Rev Respir Dis1383592849338
- BeasleyRRaffertyPHolgateST1988Adverse reaction to the non-drug constituents of nebuliser solutionsBr J Clin Pharmacol2528383358893
- BoeJDennisJHO’DriscollBR2001European Respiratory Society guidelines on the use of nebulizersEur Respir J182284211510796
- BouletLPLegrisCThibaultL1987Comparative bronchial responses to hyperosmolar saline and methacholine in asthmaThorax4295383438883
- ClayMMPaviaDNewmanSP1983Assessment of jet nebulizers for lung aerosol therapyLancet2592946136746
- ElwoodRKHoggJCParéPD1982Airway response to osmolar challenge in asthma (abstract)Am Rev Respir Dis125617065512
- EschenbacherWLBousheyHASheppardD1984Alteration in Osmolality of inhaled aerosols cause bronchoconstriction and cough, but absence of a permanent anion causes cough aloneAm Rev Respir Dis129211156696320
- Fachinformation2004aFlutide® “ready to go“ 0.5 mg/2.0 mL Suspension, Flutide® forte “ready to go” 2.0 mg/2 mL Suspension, 08/2004 GlaxoSmithKline GmbH and Co. KG, München.
- Fachinformation2004bSultanol® “ready to go”, Sultanol® forte “ready to go”, Sultanol® inhalation solution, 04/2004 GlaxoSmithKline GmbH and Co. KG, München.
- Fachinformation2005Atrovent® LS, 04/2005 Boehringer Ingelheim Pharma GmbH and Co. KG, Ingelheim am Rhein.
- FineJMGordonTThompsonJE1987The role of titratable acidity in acid aerosol-induced bronchoconstrictionAm Rev Respir Dis135826303551704
- GronbergSMagnussonPBladhN2001Chemical Compatibility of Budesonide Inhalation Suspension (Pulmicort™) with other nebulization productsAm J Respir Crit Care Med163A588
- JacobsonGAPetersonGM1995Stability of ipratropium bromide and salbutamol nebuliser admixturesInt J Pharm Pract316973
- KaminWSchwabeAKrämerI2006Inhalation solutions-which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizersJ Cyst Fibros542051316678502
- MannJSHowarthPHHolgateST1984Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicityBMJ2894696235889
- McKenzieJGronbergSCruz RiveraM2002Budesonide inhalation suspension can be nebulized with solutions containing albuterol sulphate [poster]Chest122Suppl183S
- McKenzieJECruz-RiveraM2004Compatibility of budesonide inhalation suspension with four nebulizing solutionsAnn Pharmacother389677215084687
- NagtegaalJEDe JongADe WaardWJ1997Formulation and shelf life of two solutions for inhalationZiekenhuisfarmacie13239
- O’CallaghanCMilnerADSwarbrickA1989Paradoxical bronchoconstriction in wheezing infants after nebulised preservative free isoosmolar ipratopium bromideBMJ299143334
- Pharmacopoeia Europea20055th Ed. Deutscher Apotheker Verlag, Stuttgart, Govi-Verlag-Pharmazeutischer Verlag, Eschborn.
- SchoeffelRGAndersonSDAltounyanRE1981Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and salineBMJ2831285876794821
- SchwabeAKrämerIKaminW2005Physico-chemical compatibility of ipratropium, albuterol and fluticasone nebulizer solutionsDPhG-Jahrestagung, Mainz, 05.-08.10.2005; Abstract ISBN 3-00-016844-3.
- SmaldoneGCMcKenzieJCruz RiveraM2000aEffect of nebulizer volume on drug delivery: budesonide inhalation suspensionAm J Respir Crit Care Med161A36
- SmaldoneGCMcKenzieJCruz RiveraM2000bBudesonide inhalation suspension is chemically compatible with other nebulizing formulations [abstract]Chest11898S
- van den BemtPMLAde BijlGLangenMCJ1997Validation of two methods for the analysis of salbutamol/ipratropium inhalation fluidZiekenhuisfarmacie13925